Revolution Medicines, Inc. (RVMD) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
From an external perspective, Revolution Medicines, Inc. faces warrant-related risks that could either dilute existing shareholders or leave warrant holders with securities that expire worthless. If the share price falls below the implied per-share exercise price before the December 2026 expiry, these warrants could lose all value, while remaining exercisable could introduce meaningful dilution.
Investors must weigh the uncertainty of the warrants staying in the money against the potential dilution that could occur if they are exercised in large volumes before expiration.
The average RVMD stock price target is $176.95, implying 24.17% upside potential.
To learn more about Revolution Medicines, Inc.’s risk factors, click here.